Close Menu

NEW YORK – Proteomics International Laboratories said on Tuesday its PromarkerD Hub, a software tool for calculating the risk of kidney disease in type 2 diabetes patients, has received CE marking.

PromarkerD Hub forms part of the PromarkerD test system. Receipt of the CE mark complements the CE mark that the mass spectrometry version of the test received in November, Perth, Australia-based Proteomics International said. The firm is now preparing data for potential CE marking for the PromarkerD Immunoassay, which it expects to submit in the current quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.